Egg Freezing Pilot Study

Oocyte Cryopreservation in Assisted Reproduction

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00839839

Enrollment

Registered

2009-02-10

Start date

2009-02-28

Completion date

2011-02-28

Last updated

2015-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility, Egg Freezing

Keywords

infertility, egg freezing, fertility preservation

Brief summary

University Reproductive Associates is conducting a pilot study to study the technique of egg freezing. Your participation in this study will provide us with important information to allow us to offer this technology for women wishing to freeze their eggs before cancer treatments. Your participation will include a standard IVF cycle with your eggs being frozen for a brief period of time and then transferred back to you as usual. You will receive a significant reduction in your IVF cycle cost.

Interventions

PROCEDUREOocyte Vitrification

All oocytes retrieved will be vitrified (rapidly frozen) after egg retrieval. The oocytes will then be warmed on the same day and fertilized per standard IVF-ICSI. Resulting embryos will be transferred back to the patient as per protocol.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 35 Years

Healthy volunteers

Inclusion criteria

1. 10 women between the ages of 18-35 inclusive at time of signing Informed Consent Form. 2. In good general health off of current medications which may confound response to study medications. 3. Desire to seek pregnancy actively during the study period by IVF-ICSI. 4. A normal uterine cavity must have been confirmed by either hydrosonogram or hysteroscopy within two years of entering the study. 5. Ability to use the required medications. 6. Day 3 FSH level \< 12 IU/ml

Exclusion criteria

1. Current pregnancy 2. Patients with significant anemia (Hemoglobin \< 10 mg/dL). 3. Patients enrolled simultaneously into other investigative studies that would interfere with this research study.

Design outcomes

Primary

Measure	Time frame
Incidence of Biochemical Pregnancy	1 year

Secondary

Measure	Time frame
Recovery of viable oocytes	1 year
incidence of fertilization	one year
embryo development (how many fertilized eggs undergo development to a more advanced stage)	1 year
clinical pregnancy (fetal pole visible on transvaginal ultrasound) per cycle	1 year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026